BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 8799415)

  • 1. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
    Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W; Li Y; He X; Chen Y
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up of 62 cirrhotic patients with hepatocellular carcinoma treated with chemoembolization.
    Gattoni F; Dova S; Uslenghi CM
    Minerva Chir; 2000; 55(1-2):31-7. PubMed ID: 10832281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma.
    Shim SJ; Seong J; Han KH; Chon CY; Suh CO; Lee JT
    Liver Int; 2005 Dec; 25(6):1189-96. PubMed ID: 16343071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival in 46 patients with hepatocarcinoma treated by chemoembolization].
    Gattoni F; Pompili GG; Dova S; Baldini U; Raiteri R; Sacrini A; Uslenghi CM
    Radiol Med; 1994 Sep; 88(3):228-32. PubMed ID: 7938727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
    Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.